Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAF-TIC: Pre-hospital Fibrinogen in Trauma
NCT06582420Not yet recruiting
- Sponsor
- ULS Arco Ribeirinho
- Start
- Jan 2025
- Primary completion
- Aug 2025
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Randomised, open-label trial of Fibrinogen human in trauma-induced coagulopathy (TIC) (2 arms), sponsored by ULS Arco Ribeirinho. Primary endpoints: Plasma fibrinogen levels and Administration feasibility of FC within the prehospital setting. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
Fibrinogen human
03
Conditions
trauma-induced coagulopathy (TIC)
Beyond the preview
Go deeper on NCT06582420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06582420.